 |
Ibrutinib |
|---|---|
| Trade Name | |
| Orphan Indication | Graft Versus Host Disease |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Janssen-Cilag International NV |
| |
Ibrutinib |
|---|---|
| Trade Name | |
| Orphan Indication | Graft Versus Host Disease |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Janssen-Cilag International NV |